Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common shares, no par value
-
Shares outstanding
-
42,837,925
-
Total 13F shares
-
30,627,189
-
Share change
-
-1,757,113
-
Total reported value
-
$40,115,894
-
Put/Call ratio
-
0%
-
Price per share
-
$1.31
-
Number of holders
-
53
-
Value change
-
-$3,245,437
-
Number of buys
-
18
-
Number of sells
-
31
Institutional Holders of Repare Therapeutics Inc. - Common shares, no par value (RPTX) as of Q4 2024
As of 31 Dec 2024,
Repare Therapeutics Inc. - Common shares, no par value (RPTX) was held by
53 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,627,189 shares.
The largest 10 holders included
BVF INC/IL, Blue Owl Capital Holdings LP, ORBIMED ADVISORS LLC, Versant Venture Management, LLC, ARK Investment Management LLC, Redmile Group, LLC, MPM ASSET MANAGEMENT LLC, Aquilo Capital Management, LLC, MPM BIOIMPACT LLC, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
53
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.